![Ep 1: Women and Heart Disease](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/DELV-4318_ECR_EP_1_1080x1080%20v3.png?VersionId=2khPYAPp0MjfUsIRgeVLXv8WHfkOzqiy)
Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men?
Dr Erin Michos (Johns Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they explore a variety of topics that are addressed in the latest special focus issue in the European cardiology Review journal. Discussion includes:
- Exploring the epidemiology behind CV disease in women
- Considerations for risk assessment and risk factors for women
- Are specialised heart centres for women needed?
- The long-term differences in care between men and women
- Methods of diagnostics: MINOCA, INOCA
- Where are the knowledge gaps?
- Delivering cardiac rehab
- Side effects in women vs. men
- What are the risk factors related to pregnancy? An examination of Dr Gulati's recent paper: https://www.ecrjournal.com/articles/fourth-trimester-pregnancy-predictor-cardiovascular-disease
The ECR journal special focus collection on 'Women in Heart Disease' is available NOW!
Prefer to watch in video format? Click here.
Episodes are released on the first Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com
![Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-4319_ECR_EP_2_1920x1080%20v3.png?VersionId=bukoHVbSemq1t83.c_D3Usxnt8KwPkoo&itok=rSSi6KIJ)
Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.
![View from the Thoraxcenter: TCT 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18028_TCT_Thorax_WrapUp_1920x1080.jpg?VersionId=WZPyQM5YID8Ja2tTG82JqWVrDY4PW5uI&itok=-bh0NRIv)
Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.
![ESC 23 Late-breaking Science Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-16042_IND_ESC_ThoraxReview_1920x1080.jpg?VersionId=aKMl08SiVOIisOXa0Kp6ppYSg3T1FuLX&itok=FaPhFNbK)
![View from the Thoraxcenter: ESC 23 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-08/DELV-16041_ES23_Thorax_Preview_1920x1080.png?VersionId=vIAYlNblFzty.rxRkj4FYJnXNBwsfViF&itok=7At0VBr2)
![Left Main Percutaneous Coronary Revascularization](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-07/DELV-15836_RC-Podcast_Alasnag_1920x1080.png?VersionId=3k5Ei8Hy3JGXuU01xNK8kY0YGVYZ2V.M&itok=b3BaXXuM)
![Artificial Intelligence in Atrial Fibrillation](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-05/DELV-15190_RC-Podcast_Harmon-Lopez_1920x1080%20%283%29.png?VersionId=MoT_llgyx1x4kNfpAxGS.aF18zOhApgi&itok=FJiRsHiz)
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.